Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,061 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study.
Petrillo M, Zucchetti M, Cianci S, Morosi L, Ronsini C, Colombo A, D'Incalci M, Scambia G, Fagotti A. Petrillo M, et al. Among authors: scambia g. J Gynecol Oncol. 2019 Jul;30(4):e59. doi: 10.3802/jgo.2019.30.e59. Epub 2019 Mar 1. J Gynecol Oncol. 2019. PMID: 31074245 Free PMC article. Clinical Trial.
Incidence, predictors and clinical outcome of pancreatic fistula in patients receiving splenectomy for advanced or recurrent ovarian cancer: a large multicentric experience.
Sozzi G, Petrillo M, Berretta R, Capozzi VA, Paci G, Musicò G, Di Donna MC, Vargiu V, Bernardini F, Lago V, Domingo S, Fagotti A, Scambia G, Chiantera V. Sozzi G, et al. Among authors: scambia g. Arch Gynecol Obstet. 2020 Sep;302(3):707-714. doi: 10.1007/s00404-020-05684-2. Epub 2020 Jul 9. Arch Gynecol Obstet. 2020. PMID: 32648028
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma.
Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp AR, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O'Malley DM, Armstrong DK, Banerjee S, García-Donas J, Swisher EM, Cella D, Meunier J, Goble S, Cameron T, Maloney L, Mörk AC, Bedel J, Ledermann JA, Coleman RL. Oza AM, et al. Among authors: scambia g. J Clin Oncol. 2020 Oct 20;38(30):3494-3505. doi: 10.1200/JCO.19.03107. Epub 2020 Aug 24. J Clin Oncol. 2020. PMID: 32840418 Free PMC article.
Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series.
Bizzarri N, Luigi PA, Ferrandina G, Zannoni GF, Carbone MV, Fedele C, Teodorico E, Gallotta V, Gueli Alletti S, Chiantera V, Fagotti A, Scambia G, Fanfani F. Bizzarri N, et al. Among authors: scambia g. J Cancer Res Clin Oncol. 2021 Mar;147(3):649-659. doi: 10.1007/s00432-020-03393-6. Epub 2020 Sep 30. J Cancer Res Clin Oncol. 2021. PMID: 33000339 Free PMC article.
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer.
Lorusso D, Ceni V, Muratore M, Salutari V, Nero C, Pietragalla A, Ciccarone F, Carbone V, Daniele G, Scambia G. Lorusso D, et al. Among authors: scambia g. Expert Opin Emerg Drugs. 2020 Dec;25(4):445-453. doi: 10.1080/14728214.2020.1836155. Epub 2020 Oct 20. Expert Opin Emerg Drugs. 2020. PMID: 33040627 Review.
Peritoneal HPV-DNA test in cervical cancer (PIONEER study): A proof of concept.
Bizzarri N, Pedone Anchora L, Cattani P, De Vincenzo R, Marchetti S, Conte C, Chiantera V, Gallotta V, Gueli Alletti S, Vizzielli G, Costantini B, Fagotti A, Fanfani F, Scambia G, Ferrandina G. Bizzarri N, et al. Among authors: scambia g. Int J Cancer. 2021 Mar 1;148(5):1197-1207. doi: 10.1002/ijc.33380. Epub 2020 Nov 27. Int J Cancer. 2021. PMID: 33152105
2,061 results